CD30 ligation induces nuclear factor‐ϰB activation in human T cell lines

Authors:

Abstract
CD30 is a recently described member of the tumor necrosis factor/nerve growth factor receptor superfamily. In this report, we show that following incubation of L540 cells (Hodgkin's disease‐derived, T cell‐like, CD30+ cells) with the agonistic anti‐CD30 monoclonal antibodies (mAb) M44 and M67, two nuclear factor (NF)‐ϰB DNA binding activities were induced in nuclear extracts, as determined in gel retardation assays. The effect of the mAb towards NF‐ϰB activation was rapid, as it occurred within 20 min, and was sustained for up to 6h. By comparison, an isotype‐matched antibody had no effect on NF‐ϰB activation. Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30‐mediated NF‐ϰB activation correlated with the proportion of CD30+ cells. In all cell lines investigated, the NF‐ϰB complexes induced following CD30 engagement were shown to contain p50 NF‐ϰB1, p65 RelA, and possibly other transcription factors. Collectively, our results demonstrate that nuclear translocation and activation of NF‐ϰB rank among the short‐term cellular responses elicited following CD30 ligation.

This publication has 30 references indexed in Scilit: